Waqar, S. N., Cuppens, K., Campelo, R. G., Dziadziuszko, R., Carcereny, E., Yang, T., Shih, J., Dutcher, G., Novello, S., Chmielewska, I., Kalinka, E., Şendur, M. A. N., Wakuda, K., Tyulyandina, A., Hinzmann, M., Shi, X., Bodla, S., Papadopoulos, K. P. (2025). First-line (1L) datopotamab deruxtecan (Dato-DXd) + rilvegostomig in advanced or metastatic non-small cell lung cancer (a/mNSCLC): Results from TROPION-Lung04 (cohort 5).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.8521